![]() |
AGIO | Agios Pharmaceuticals, Inc. |
Pharmaceutical Preparations |
Book value per $ invested | $ 2.44 |
Leverage | 6.83% |
Market Cap | $ 1.9B |
PE | 2.80 |
Dividend Yield | 0.00% |
Profit | $ 666.9m |
Margin | 1550.71% |
Agios Pharmaceuticals, Inc., a biopharmaceutical company, is dedicated to drug discovery and development in the field of cellular metabolism and adjacent areas of biology. The company is headquartered in Cambridge, Massachusetts.